These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 20093143)

  • 1. The flavin inhibitor diphenyleneiodonium renders Trichomonas vaginalis resistant to metronidazole, inhibits thioredoxin reductase and flavin reductase, and shuts off hydrogenosomal enzymatic pathways.
    Leitsch D; Kolarich D; Duchêne M
    Mol Biochem Parasitol; 2010 May; 171(1):17-24. PubMed ID: 20093143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trichomonas vaginalis: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance.
    Leitsch D; Kolarich D; Binder M; Stadlmann J; Altmann F; Duchêne M
    Mol Microbiol; 2009 Apr; 72(2):518-36. PubMed ID: 19415801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia.
    Leitsch D; Burgess AG; Dunn LA; Krauer KG; Tan K; Duchêne M; Upcroft P; Eckmann L; Upcroft JA
    J Antimicrob Chemother; 2011 Aug; 66(8):1756-65. PubMed ID: 21602576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of flavin reductase and alcohol dehydrogenase-1 (ADH1) in metronidazole-resistant isolates of Trichomonas vaginalis.
    Leitsch D; Drinić M; Kolarich D; Duchêne M
    Mol Biochem Parasitol; 2012 Jun; 183(2):177-83. PubMed ID: 22449940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trichomonas vaginalis flavin reductase 1 and its role in metronidazole resistance.
    Leitsch D; Janssen BD; Kolarich D; Johnson PJ; Duchêne M
    Mol Microbiol; 2014 Jan; 91(1):198-208. PubMed ID: 24256032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative pathway of metronidazole activation in Trichomonas vaginalis hydrogenosomes.
    Hrdý I; Cammack R; Stopka P; Kulda J; Tachezy J
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5033-6. PubMed ID: 16304169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogenosomes of laboratory-induced metronidazole-resistant Trichomonas vaginalis lines are downsized while those from clinically metronidazole-resistant isolates are not.
    Wright JM; Webb RI; O'Donoghue P; Upcroft P; Upcroft JA
    J Eukaryot Microbiol; 2010; 57(2):171-6. PubMed ID: 20015182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in
    Graves KJ; Novak J; Secor WE; Kissinger PJ; Schwebke JR; Muzny CA
    Parasitology; 2020 Nov; 147(13):1383-1391. PubMed ID: 32729451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of multiple hydrogenosomal proteins associated with organelle metabolism and high-level drug resistance in trichomonads.
    Land KM; Clemens DL; Johnson PJ
    Exp Parasitol; 2001 Feb; 97(2):102-10. PubMed ID: 11281707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of iron on metronidazole activity against Trichomonas vaginalis in vitro.
    Elwakil HS; Tawfik RA; Alam-Eldin YH; Nassar DA
    Exp Parasitol; 2017 Nov; 182():34-36. PubMed ID: 28935536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trichomonads, hydrogenosomes and drug resistance.
    Kulda J
    Int J Parasitol; 1999 Feb; 29(2):199-212. PubMed ID: 10221623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Trichomonas vaginalis clinical isolates to evaluate correlation of gene expression and metronidazole resistance.
    Mead JR; Fernadez M; Romagnoli PA; Secor WE
    J Parasitol; 2006 Feb; 92(1):196-9. PubMed ID: 16629339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auranofin inactivates Trichomonas vaginalis thioredoxin reductase and is effective against trichomonads in vitro and in vivo.
    Hopper M; Yun JF; Zhou B; Le C; Kehoe K; Le R; Hill R; Jongeward G; Debnath A; Zhang L; Miyamoto Y; Eckmann L; Land KM; Wrischnik LA
    Int J Antimicrob Agents; 2016 Dec; 48(6):690-694. PubMed ID: 27839893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of protease inhibitors against Giardia duodenalis and metronidazole-resistant Trichomonas vaginalis.
    Dunn LA; Andrews KT; McCarthy JS; Wright JM; Skinner-Adams TS; Upcroft P; Upcroft JA
    Int J Antimicrob Agents; 2007 Jan; 29(1):98-102. PubMed ID: 17137752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Nitroimidazole drugs effective against metronidazole-resistant Trichomonas vaginalis and Giardia duodenalis.
    Upcroft JA; Dunn LA; Wright JM; Benakli K; Upcroft P; Vanelle P
    Antimicrob Agents Chemother; 2006 Jan; 50(1):344-7. PubMed ID: 16377707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitroimidazole action in Entamoeba histolytica: a central role for thioredoxin reductase.
    Leitsch D; Kolarich D; Wilson IB; Altmann F; Duchêne M
    PLoS Biol; 2007 Aug; 5(8):e211. PubMed ID: 17676992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug targets and mechanisms of resistance in the anaerobic protozoa.
    Upcroft P; Upcroft JA
    Clin Microbiol Rev; 2001 Jan; 14(1):150-64. PubMed ID: 11148007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Indicators of Drug Resistance in the Highly Repetitive Genome of Trichomonas vaginalis.
    Bradic M; Warring SD; Tooley GE; Scheid P; Secor WE; Land KM; Huang PJ; Chen TW; Lee CC; Tang P; Sullivan SA; Carlton JM
    Genome Biol Evol; 2017 Jun; 9(6):1658-1672. PubMed ID: 28633446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the flavoprotein inhibitor, diphenyleneiodonium sulfate, on ex vivo organic nitrate tolerance in the rat.
    Ratz JD; McGuire JJ; Anderson DJ; Bennett BM
    J Pharmacol Exp Ther; 2000 May; 293(2):569-77. PubMed ID: 10773030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro sensitivity of Trichomonas vaginalis to DNA topoisomerase II inhibitors.
    Petmitr PC; Ramdja M; Kajorndechakiat S
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):118-22. PubMed ID: 11023077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.